Bvf Inc Voyager Therapeutics, Inc. Transaction History

Bvf Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.82 - $10.09 $5.06 Million - $10.6 Million	-1,049,100 Reduced 88.23%	140,000 $827,000
Q1 2022 May 16, 2022	BUY	$2.75 - $9.44 $3.21 Million - $11 Million	1,166,900 Added 5256.31%	1,189,100 $9.06 Million
Q4 2021 Feb 14, 2022	BUY	$2.47 - $5.55 $54,834 - $123,210	22,200 New	22,200 $60,000
Q2 2019 Aug 14, 2019	SELL	$19.18 - $27.88 $5.95 Million - $8.65 Million	-310,299 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$8.0 - $19.66 $2.48 Million - $6.1 Million	310,299 New	310,299 $5.94 Million

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $219M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.